Condition: Endometrial Cancer · Sponsor: Qilu Hospital of Shandong University
The primary goal of this prospective study is to define the efficacy of the sentinel lymph node biopsy (SLNB) procedure by comparing different method performed in patients with endometrial cancer. The aim of this study is to investigate whether the detection rate of sentinel lymph node (SLN) with two different injection sites may be increased compared to the standard use with single site (cervix) injection in endometrial cancer.
This description comes directly from the study's public registry record.
Jin Peng, PhD · 86-18560088205 · jin_peng@outlook.com
Youzhong Zhang, PhD · 86-18560081866 · zhangyouzhong@vip.sina.com
Always discuss trial participation with your own doctor first.
| Qilu Hospital，Shandong University | Jinan, Shandong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06656949